This article provides an interpretation of a review published in the 2021 issue of "Nature Reviews Drug Discovery", which analyzes the history and trends of peptide drug development over the past 100 years.

Janux Therapeutics Reports Promising Preliminary Results on Tolerability and Therapeutic Impact in Progressive Dose Studies for Prostate Cancer Therapy JANX007 and Solid Cancer Treatment JANX008.

On February 21, 2024, Innovent Biologics and ImmVirX unveiled a partnership for clinical research on a combo therapy using sintilimab and the cancer-fighting virus IVX037.

Alvotech and Teva have received FDA clearance for their product SIMLANDI® (adalimumab-ryvk), a novel substitutable biosimilar to Humira®.

Donepezil, a small molecule, acts as an acetylcholinesterase inhibitor, preventing the breakdown of the neurotransmitter acetylcholine in the brain, thus helping improve cognition.

Encoded Therapeutics Receives UK Regulatory Nod for Experimental Gene Treatment ETX101 Aimed at Dravet Syndrome.

Phenylephrine, a small drug molecule, acts as an alpha-1 adrenergic receptor agonist to help dilate the pupil for eye exams and surgeries.

Oscotec/Adel has commenced the initial human administration phase of their Phase 1 trial, testing the anti-tau antibody ADEL-Y01 as a potential treatment for Alzheimer's.

TAR-210 is an intravesical drug delivery system that is designed to provide local, continuous release of erdafitinib.

Immunofoco Reveals U.S. and China Regulators Grant Green Light to IND Submissions for Novel EpCAM CAR-T Therapy Aimed at Treating Severe Solid Cancers.

Metoclopramide, marketed under the brand name REGLAN®, is a small molecule drug that acts as a dopamine-2 (D2) antagonist.

OncoC4 Reveals Initial Participant with Late-Stage Prostate Cancer Receives Dose in Early to Mid-Stage Study for BNT316/ONC-392, a Collaborative Effort with BioNTech.